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Abstract: 
The goal of this research is to develop a mouse model with a mutation in the CYP1B1 
gene that would result in a phenotype similar to that seen in Primary Congenital Glaucoma 
(PCG) human patients. Using this mouse model, structural changes in eyes and upregulation of 
certain proteins were observed compared to a normal mouse. Examination of the cornea, iris, 
retina, ciliary body, and iridocorneal angle showed structural changes in CYP1B1 mice compared 
to wild type mice. These results were similar to those described in studies using other animal 
models. Furthermore, the current study confirmed earlier findings in other animal models, 
showing that P53 is upregulated in the cornea, retina, and iridocorneal angle of a CYP1B1 mutant 
compared to the wild-type. This suggests that a mutation in the CYP1B1 gene in a mouse model 
results in a phenotype similar to that seen in human patients with PCG. Therefore, this model 
could be used to investigate possible treatments for PCG.  
 
Introduction: 
Glaucoma is the leading cause of blindness, affecting roughly 70 million people 
worldwide (Quigley & Broman, 2006). Three major types of Glaucoma persist in the human 
population: Primary Open Angle Glaucoma (POAG), Primary Angle Closure Glaucoma 
(PACG), and Primary Congenital Glaucoma (PCG) (Bouhenni et al. 2012). Primary Congenital 
Glaucoma (PCG) is the most prevalent form of pediatric glaucoma, affecting approximately 1 in 
30,000 live births (Giampani & Giampani, 2011). PCG is an autosomal recessive disease 
affecting the eye. If left untreated, PCG can cause visual impairment and blindness. Furthermore, 
at least 50% of individuals with this disorder will become legally blind (Levy et al. 2005). 
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  PCG is present at birth, but symptoms may not be observed until infancy or early 
childhood (Giampani & Giampani, 2011). PCG affects all races, but male patients are found to 
have a higher incidence (Giampani & Giampani, 2011). Signs and symptoms include: excessive 
tearing, sensitivity to light, spasms of the eye, enlarged eye, and cloudy appearance of the cornea 
(Giampani & Giampani, 2011). There is currently no treatment for this disease other than 
surgical procedures which can have further complications, and is not completely curative (Levy 
et al. 2005). Current surgical procedures used are Goniotomy and trabeculotomy, with highest 
success rates when PCG is detected earlier in development (Giampani & Giampani, 2011). 
Three genes have been isolated as the most likely cause of this disorder: cytochrome p 
450 b1 (CYP1B1), latent transforming binding protein 2 (LTBP2) and TEK (Bouhenni et al. 
2012). This research specifically looks at the mutation of the CYP1B1 gene in mice. The 
CYP1B1 gene is expressed in tissues of the anterior chamber of the eye (Sarfarazi & Stoilov, 
2000). Mutations of this gene impact eye development, specifically in the cornea, iris, ciliary 
body, and iridocorneal angle impacting flow of aqueous humor throughout the eye (Vasiliou & 
Gonzalez, 2008). With the build-up of this fluid in the eye, patients have elevated intraocular 
pressure, which creates pressure against the optic nerve, damaging retinal neurons in the eye 
leading to visual impairment as well as the loss of retina cells. Currently, there is no ideal animal 
model that captures the complexity of this disease in human patients (Bouhenni et al. 2012). 
 
Methods:  
Mouse Model: Eyes from mice carrying a mutation in CYP1B1 (Cyp1b1-/- ) were compared to 
eyes from age-matched healthy mice (WT).  
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Histology: Immediately after enucleation, eyes were fixed in 10% Buffered Neutral Formalin, 
processed and fixed in paraffin. Paraffin blocks were cut into thin (6 μm) tissue sections using a 
microtome and placed on pretreated glass slides. 
Hematoxylin and Eosin (H&E) Staining: The sections were stained using H&E staining. Eosin 
is an acidic dye that is negatively charged and stains basic structures red or pink (Fischer et al. 
2008). Hematoxylin is a basic dye used to stain acidic structures purplish blue (Fischer et al. 
2008). The staining makes it possible for the cells to be visible under a microscope.  
Microscopy: H&E stained sections were examined using an Olympus bright field microscope at 
10x and 20x magnifications. Images of the iridocorneal angle, cornea, and iris were qualitatively 
compared between Cyp1b1-/- and WT mice.  
Immunohistochemistry: The amount of protein P53 were examined between Cyp1b1-/- and WT 
mice using DAPI (4′,6-diamidino-2-phenylindole) is a the blue-fluorescent DNA stain used and 
CY3 (cyanine dye 3) as the green-fluorescent protein counterstain. 
Statistical Analysis: The mean intensity of fluorescent light tagging the protein P53 by CY3 
green counterstain was measured using ImageJ and were tested for statistical significance by an 
ANOVA single factor test. 
Results of H&E stained sections: 
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Figure 1. Images of the cornea from (A) Cyp1b1
-/-   mutant mouse and (B) wild-type mouse. Images taken at 20x 
magnification. Scale bar: 100 μm. Labels within the cornea are the following: (E) Epithelium, (S) Stroma, and (En) 
Endothelium. Note the irregular organization of the collagen fibers in in the PCG corneal stroma (S) and a thicker 
epithelium cell layer (E) compared to the wild-type cornea. 
 
 
 
 
 
Figure 2.  Images of the iris from (A) Cyp1b1
-/- 
mouse and (B) wild-type mouse. Images taken at 10x 
magnification. Scale bar: 100 μm. Labels within this image are the following: (I) Iris, (CB) Ciliary Body, (C) 
Cornea. Note the density and lack of the iris process (I) in the Cyp1b1
-/- 
mouse as well as the thick ciliary body 
(CB) and cornea (C). 
 
 
 
 
 
 
Figure 3. Images of the ciliary body (A) Cyp1b1
-/- 
mouse and (B) wild-type mouse. Images taken at 20x 
magnification. Scale bar: 100 μm. Labels within this image are the following: (I) Iris and (CB) Ciliary Body. Note 
the altered structure of the ciliary body (CB) as it is compressed in the Cyp1b1
-/- 
mouse compared to the wild-type 
mouse. 
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Figure 4. Images of iridocorneal angle histology of (A) Cyp1b1
-/- 
mouse (B) wild-type mouse. Images taken at 20x 
magnification. Scale bar: 100 μm. Labels within this image are the following: (R) Retina, (CB) Ciliary Body, (C) 
Cornea, and (AC) Anterior Chamber Note the altered structure of the iridocorneal angle (arrow) of the Cyp1b1
-/- 
mutant mouse compared to the normal mouse angle (arrow). Cyp1b1
-/- 
mouse has a smaller anterior chamber (AC) 
and denser ciliary body (CB) when compared to the wild-type mouse. 
 
 
 
 
 
 
 
 
 
Figure 5. Images of the retina (A) Cyp1b1
-/- 
mouse and (B) wild-type mouse. Images taken at 20x magnification. 
Scale bar: 100 μm.  Note the layers of the retina, (1) sclera (2) choroid (3) photoreceptors (4) outer nuclear layer (5) 
outer plexiform layer (6) inner nuclear layer (7) inner plexiform layer (8) ganglion cells,  as it is more tightly packed 
in the Cyp1b1
-/- 
mouse compared to the wild-type mouse.  
Analysis of H&E stained sections: 
 Differences between the cornea of a mutant mouse and a wild-type mouse were shown in 
figure 1. Within the stroma of the mutant cornea, the collagen fibers were more condensed and 
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did not show the typical organization as displayed in the wild-type stroma. The mutant cornea 
also appeared to contain more stromal fibroblast cells, stained purple within the stroma, 
compared to the wild-type mouse. The epithelial cell layer within the mutant is thicker and more 
tightly packed with nuclei compared to the very organized epithelial layer observed in normal 
mice. This may explain the loss of corneal transparency and corneal cloudiness that is observed 
in PCG patients.  
Differences between the irises of the Cyp1b1 mutant mouse and the wild-type mouse 
were illustrated in figure 2. It was obvious that the iris was much thicker and denser in the 
mutant mouse compared to the wild-type mouse. Furthermore, the mutant mouse’s iris was much 
shorter and did not extend around the eye compared to the rich iris of the wild-type mouse. The 
iris functions to insure passages of proper amounts of light into the eye, but in the mutant mouse 
the iris muscle would be too dense to allow proper muscle contraction when exposed to light. 
This may explain the observation that PCG patients have a higher sensitivity to light (reference).  
 Differences in the ciliary bodies of the mutant mouse and wild-type mouse were shown in 
figure 3. The mutant mouse had much condensed ciliary body processes compared to the long 
and differentiated processes of the wild-type mouse. It was also noted that the ciliary body in the 
wild-type mouse was highly vascularized, shown by presence of pink blood vessels within the 
processes. In contrast, little or no vascularization was observed in tightly pack ciliary bodies of 
the mutant eye. The ciliary body plays an important role in the formation of the iridocorneal 
angle, shown in Figure 4. The thick ciliary body, together with the abnormal iris, and cornea 
formed a thick and immature angle, indicated by the arrow. The angle was much narrower and 
the processes were much thicker compared to those of the wild-type. Furthermore, the anterior 
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chamber of the eye was much larger in the wild-type mouse when compared to the mutant 
mouse. This may explain why proper drainage of the aqueous fluid out of the eye is 
compromised and interocular pressure rises in PCG patients. Analyzing the iridocorneal angle of 
the wild-type mouse revealed that the cells were differentiated and the angle was open for proper 
aqueous flow.  
 Figure 5 compares images taken from the retina of the mutant mouse and wild-type 
mouse. The cellular layers of the retina within the mutant mouse were more tightly packed 
together when compared to the wild-type mouse. The tight compact was specifically obvious in 
the photoreceptor layer and the ganglion cell layer, two cellular layers crucial for transducing 
light signals from the environment to nerve impulses in the optic nerve. The built-up pressure in 
these areas would explain the eventually loss of vision if this condition were to persist, as the 
cells are unable to function normally and die. 
Results of  Immunohistochemistry: 
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Figure 6. Immunohistochemical detection of protein P53 within the cornea from (A) and (C) Cyp1b1
-/-   mutant 
mouse and (B) and (D) wild-type mouse using fluorescent IHC images. Image (A) represents negative control for 
Cyp1b1
-/-   mutant mouse, Image (B) represents negative control for wild-type mouse, Image (C) positive control 
tagged with antibody for P53 in Cyp1b1
-/-   mutant mouse, and Image (D) represents positive control for wild-type 
mouse.  Images taken at 20x magnification. Scale bar: 100 μm.  
 
 
 
Table 1: Shows the average light intensity of the green-fluorescent dye tagging protein P53 from cornea samples 
shown in Figure 6. Sample size (n=4). Data proved to be statistically significant between groups by ANOVA single 
factor test (P-value: 4.80x10-
5
). 
 
 
 
 
 
 
 
 
 
Figure 7.  Immunohistochemical detection of protein P53 within the retina from (A) and (C) Cyp1b1
-/-   mutant 
mouse and (B) and (D) wild-type mouse using fluorescent IHC images. Image (A) represents negative control for 
Cyp1b1
-/-   mutant mouse, Image (B) represents negative control for wild-type mouse, Image (C) positive control 
tagged with antibody for P53 in Cyp1b1
-/-   mutant mouse, and Image (D) represents positive control for wild-type  
Cornea: Average Intensity Variance: P-value: 
Positive Cyp1b1 mouse (C) 40.612 0.47 4.80x10-5 
Positive wild-type mouse (D) 32.379 1.33  
Negative Cyp1b1 mouse (A) 33.435 0.47  
Negative wildtype mouse (B) 34.229 1.33  
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mouse.  Images taken at 20x magnification. Scale bar: 100 μm.  
 
 
 
Table 2: Shows the average light intensity of the green-fluorescent dye tagging protein P53 from retina samples 
shown in Figure 7. Sample size (n=4).  Data proved to be statistically significant between groups by ANOVA single 
factor test (P-value: 1.16x10-9).  
 
 
 
 
 
 
 
 
 
 
Figure 8.  Immunohistochemical detection of protein P53 within the iridocorneal angle from (A) and (C) Cyp1b1
-/-   
mutant mouse and (B) and (D) wild-type mouse using fluorescent IHC images. Image (A) represents negative 
control for Cyp1b1
-/-   mutant mouse, Image (B) represents negative control for wild-type mouse, Image (C) positive 
control tagged with antibody for P53 in Cyp1b1
-/-   mutant mouse, and Image (D) represents positive control for 
wild-type mouse.  Images taken at 20x magnification. Scale bar: 100 μm.  
Retina: Average Intensity: Variance: P-value: 
Positive Cyp1b1 mouse 63.715 1.34 1.16x10-9 
Positive wild-type mouse 47.624 0.618  
Negative Cyp1b1 mouse 40.623 0.94  
Negative wildtype mouse 27.026 2.03  
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Table 3: Shows the average light intensity of the green-fluorescent dye tagging protein P53 from iridocorneal angle 
samples shown in Figure 8. Sample size (n=4). Data proved to be statistically significant between groups by 
ANOVA single factor test (P-value: 2.31x10
-13
). 
Analysis of Immunohistochemistry: 
 Florescent images of the cornea, retina, and iridocorneal angle comparing the protein 
levels of P53 with in the tissue revealed that the Cyp1b1-/-   mutant mouse contained 
significantly higher amounts. DAPI (4′,6-diamidino-2-phenylindole) was used as the blue-
fluorescent DNA stain and CY3 (cyanine dye 3) as the green-fluorescent protein counterstain 
tagging P53. The intensity of green-fluorescent was measured using ImageJ as a measure for P53 
within the tissue and compared using a single-factor ANOVA to prove statistical significance 
between the negative and positive control for the Cyp1b1-/-   mutant mouse and the negative and 
positive control of the wild-type mouse. The highest mean intensity for the cornea was found to 
be the positive control for the Cyp1b1-/-   mutant mouse, 40.612. This value was statistically 
significant from the negative controls and positive wild-type cornea with a p-value of 4.80x10-5. 
Image C in Figure 6 showed the highly fluorescent stroma of the mutant cornea, while little or no 
green fluorescent could be detected in the wild-type cornea.  
Similarly, the highest mean intensity for the retina was found to be the positive control 
for the Cyp1b1-/-   mutant mouse, 63.715. This value was statistically significantly compared to 
the other images taken from negative controls and the positive wild-type retina with a p-value of 
1.16x10-9. P53 expression in the mutant mouse retina was high (staining intensity) in the 
Iridocorneal Angle: Average Intensity: Variance: P-value: 
Positive Cyp1b1 mouse 62.124 0.501 2.31x10-13 
Positive wild-type mouse 28.029 0.239  
Negative Cyp1b1 mouse 15.375 0.258  
Negative wildtype mouse 24.024 0.051  
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photoreceptor layer, outer plexiform layer, and inner plexiform layer compared to the wild-type 
retina that showed a faint fluorescent signal only in the photoreceptor layer (Fig. 7). 
 Lastly, the highest mean intensity for the iridocorneal angle was found to be the positive 
control for the Cyp1b1-/-   mutant mouse, 62.124. This value was also statistically significantly 
larger than those from negative controls and the positive wild-type retina with a p-value of 
2.31x10-13. In the mutant eye, strong P53 expression within the structures around the iridocorneal 
angle: ciliary body, iris, and cornea, was observed (Fig. 8). In contrast, there was only faint P53 
staining in those structures in the wild-type mouse eye. In summary, protein p53 was clearly 
upregulated in the cornea, retina, and iridocorneal angle of mice with a mutation in the Cyp1b1 
gene.  
Discussion: 
After analyzing and comparing images taken from sections of mice eyes with a mutation 
in the Cyp1b1 gene to a normal wild-type mouse, it can be concluded that the mutation causes a 
structural changes to the cornea, iris, retina, ciliary body, and iridocorneal angle. These changes 
are similar to those found in human patients with PCG, blocking proper flow of aqueous humor 
throughout the eye and causing blindness by build-up pressure against the optic nerve (Vasiliou 
& Gonzalez, 2008). Mutations in the mouse Cyp1b1 gene also caused upregulation of the protein 
P53. This is not surprising because P53 is believed to be a tumor/cancer suppressor, playing an 
important role in regulating cell proliferation, and is upregulated in response to DNA and tissue 
damages (Danilova et al. 2010). In summary, this study provides a mouse model with a mutation 
in the CYP1B1 gene that results in a phenotype similar to that seen in human patients with PCG 
and can be used to test alternative treatments for PCG.  
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